PremiumThe FlyTerns Pharmaceuticals reports Q3 EPS (28c), consensus (32c) Wingstop upgraded, Estee Lauder downgraded: Wall Street’s top analyst calls Terns Pharmaceuticals initiated with an Outperform at Oppenheimer PremiumThe FlyUnusually active option classes on open September 11th Terns Pharmaceuticals 11.919M share Spot Secondary priced at $10.50 Oracle reports Q1 beat, EU says Apple must pay: Morning Buzz PremiumThe FlyUnusually active option classes on open September 9th Terns Pharmaceuticals’ TERN-601 Shows Promise for Obesity Management Terns Pharmaceuticals announces Phase 1 trial results of TERN-601